Elucidation of gene function using C-5 propyne antisense oligonucleotides

Nature Biotechnology

Volumn 14, Issue 9, 1996, Pages 1139-1145

  Flanagan, W Michael ^a   Su, Leon L ^a   Wagner, Richard W ^a  

^a GILEAD SCIENCES   (United States)

Author keywords

Antisense oligonucleotides; C 5 propyne phosphorothioate oligonucleotides; Cationic lipids; Cell cycle; Cyclin Bl; Gene delivery; P34cdc2

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; PHOSPHOROTHIOIC ACID;

ARTICLE; BREAST CANCER; CELL CYCLE; DIAGNOSTIC TEST; DOSE RESPONSE; ENZYME ACTIVITY; GENE FUNCTION; GENE TARGETING; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN ANALYSIS; REPRODUCIBILITY; TARGET CELL;

BASE SEQUENCE; BIOTECHNOLOGY; BREAST NEOPLASMS; CDC2 PROTEIN KINASE; CELL CYCLE; CELL DIVISION; CYCLIN B; FEMALE; GENE EXPRESSION; GENE TARGETING; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; RNA, MESSENGER; RNA, NEOPLASM; THIONUCLEOTIDES; TUMOR CELLS, CULTURED;

EID: 0029737877     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0996-1139     Document Type: Article

References (54)

1. Milligan, J.F., Matteucci, M.D, and Martin, J.C. 1993. Current concepts in anti-sense drug design. J. Med. Chem. 36:1923-1937.
2. Stein, C.A. and Cheng, Y.-C. 1993. Antisense oligonucleotides as therapeutic agents—is the bullet really magical? Science 261:1004-1012.
3. Wagner, R.W. 1994. Gene inhibition using antisense oligodeoxynucleotides. Nature 372:333-335.
4. Wagner, R.W. 1995. Toward a broad-based antisense technology. Antisense Res. and Dev. 5:113-114.
5. Nurse, P. 1994. Ordering S phase and M phase in the cell cycle. Cell 79:547-550.
6. Sherr, C.J. 1994. G1 phase progression: cycling on cue. Cell 79:551-555.
7. Heichman, K.A. and Roberts, J.M. 1994. Rules to replicate by. Cell 79:557-562.
8. King, R.W., Jackson, P.K., and Kirshner, M.W. 1994. Mitosis in transition. Cell 79:563-571.
9. Norbury, C. and Nurse, P. 1992. Animal cell cycles and their control. Ann. Rev. Biochem. 61:441-470.
10. cdc2. Cell 58:833-846.
11. Kumagai, A. and Dunphy, W.G. 1991. The cdc25 protein controls tyrosine dephos-phorylation of the cdc2 protein in a cell-free system. Cell 64:903-914.
12. cdc2. Cell 67:197-211.
13. Desai, D., Gu, Y., and Morgan, D.O. 1992. Activation of human cyclin-dependent kinases in vitro. Molec. Biol. Cell 3:571-582.
14. Fisher, T.L., Terhorst, T., Cao, X., and Wagner, R.W. 1993. Intracellular disposition and metabolism of fluorescently-labeled unmodified and modified oligonucleotides microinjected into mammalian cells. Nucl. Acids Res. 21:3857-3865.
15. Th’ng, J.P.H., Wright, P.S., Hamaguchi, J., Lee, M.G., Norbury, C.J., Nurse, P., et al. 1990. The FT210 cell line is a mouse G2 phase mutant with a temperature-sensitive CDC2 gene product. Cell 63:313-324.
16. Riabowol, K., Draetta, G., Brizuela, L., Vandre, D., and Beach, D. 1989. The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells. Cell 57:393-401.
17. van den Heuvel, S. and Harlow, E. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050-2054.
18. Furukawa, Y., Piwnica-Worms, H., Ernst, T.J., Kanakura, Y., and Griffin, J.D. 1990. Cdc2 gene expression at the G1 to S transition in human T lymphocytes. Science 250:805-808.
19. Shaw, J.P., Kent, K., Bird, J., Fishback, J., and Froehler, B. 1991. Modified deoxy-oligonucleotides stable to exonuclease degradation in serum. Nucl. Acids Res. 19:747-750.
20. Welch, P.J. and Wang, J.Y.J. 1992. Coordinated synthesis and degradation of cdc2 in the mammalian cell cycle. Proc. Natl. Acad. Sci. USA 89:3093-3097.
21. Stein, C.A. and Krieg, A.M. 1994. Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res. Dev. 4:67-69.
22. Mouthon, M.A., Mitjavila, M.T., Marquet, J., Vainchenker, W., and Wendling, F. 1994. Erroneous results of 3H-thymidine incorporation are related to position of thymidine residues in oligodeoxynucleotides. Exp. Hematol. 22:384-387.
23. Barton, C.M. and Lemoine, N.R. 1995. Antisense oligonucleotides directed against p53 have antiproliferative effects unrelated to effects on p53 expression. Brit. J. Cancer 71:429-437.
24. Krieg, A.M., Yi, A.K., Matson, S., Waldschmidt, T.J., Bishop, G.A., Teasdale, R., et al. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546-549.
25. Morishita, R., Gibbons, G.H., Ellison, K.E., Nakajima, M., von der Leyen, H., Zhang, L., et al. 1994. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. J. Clin. Invest. 93:1458-1464.
26. Morishita, R., Gibbons, G.H., Ellison, K.E., Nakajima, M., Zhang, L., Kaneda, Y., et al. 1993. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl. Acad. Sci. USA 90:8474-8478.
27. Vesely, J., Havlicek, L., Stinad, M., Blow, J., Donnela-Deana, A., Pinna, L., et al. 1994. Inhibition of cyclin-dependent kinases by purine analogues. Eur. J. Biochem. 224:771-786.
28. Hanvey, J.C., Peffer, N.J., Bisi, J.E., Thomason, S.A., Cadilla, R., Josey, J.A., et al. 1992. Antisense and antigene properties of peptide nucleic acids. Science 258:1481-1485.
29. Wagner, R.W., Matteucci, M.D., Lewis, J.G., Gutierrez, A.J., Moulds, C., and Froehler, B.C. 1993. Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science 260:1510-1513.
30. Bennett, C.F., Chiang, M.Y., Chan, H., Shoemaker, J.E., and Mirabelli, C.K. 1992. Cationic lipids enhance cellular uptake and activity of phosphorothioate anti-sense oligonucleotides. Mol. Pharmacol. 41:1023-1033.
31. Capaccioli, S., Di Pasquale, G., Mini, E., Mazzei, T., and Quattrone, A. 1993. Cationic lipids improve antisense oligonucleotide uptake and prevent degradation in cultured cells and in human serum. Biochem. Biophys. Res. Commun. 197:818-825.
32. Lewis, J.G., Lin, K.Y., Kothavale, A., Flanagan, W.M., Matteucci, M.D., DePrince, R.B., et al. 1996. A serum-resistant cytofectin for cellular delivery of antisense oligonucleotides and plasmid DNA. Proc. Natl. Acad. Sci. USA 93:1112-1116.
33. Moulds, C., Lewis, J.G., Froehler, B.C., Grant, D., Huang, T., Milligan, J.F., et al. 1995. Site and mechanism of antisense inhibition by C-5 propyne oligonucleotides. Biochemistry 34:5044-5053.
34. Ohtsubo, M. and Roberts, J.M. 1993. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259:1908-1912.
35. Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J.W., Elledge, S., et al. 1992. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 257:1689-1694.
36. Norbury, C., Blow, J., and Nurse, P. 1991. Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J. 10:3321-3329.
37. Solomon, M.J., Lee, T., and Kirschner, M.W. 1992. Role of phosphorylation in p34cdc2 activation: Identification of an activating kinase. Mol. Biol. Cell 3:13-27.
38. Fenster, S.D., Wagner, R.W., Froehler, B.C., and Chin, D.J. 1994. Inhibition of Human Immunodeficiency Virus type-1 env expression by C-5 propyne oligonucleotides specific for Rev Response element stem loop V. Biochemistry 33:8391-8398.
39. Bennett, C.F., Condon, T.P., Grimm, S., Chan, H., and Chiang, M-Y. 1994. Inhibition of endothelial cell adhesion molecule expression with antisense oligonucleotides. J. Immunol. 152:3530-3540.
40. Monia, B.P., Johnston, J.F., Ecker, D.J., Zounes, M.A., Lima, W.F., and Freier, S.M. 1992. Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides. J. Biol. Chem. 267:19954-19962.
41. Duroux, I., Godard, G., Boidot-Forget, M., Schwab, G., Helene, C., and Saison-Behmoaras, T. 1995. Rational design of point mutation-selective antisense DNA targeted to codon 12 of Ha-ras mRNA in human cells. Nucl. Acids Res. 23:3411-3418.
42. Wagner, R.W., Matteucci, M.D., Grant, D., Huang, T., and Froehler, B.C. 1996. Potent and selective inhibition of gene expression by an antisense heptanucleotide. Nature Biotechnology 14:840-844.
43. Monia, B.P., Lesnik, E.A., Gonzalez, C., Lima, W.F., McGee, D., Guinosso, C.J., et al. 1993. Evaulation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 268:14514-14522.
44. Larrouy, B., Boiziau, C., Sprout, B., and Toulme, J.J. 1995. RNase H is responsible for the non-specific inhibition of in vitro translation by 2′-O-alkyl chimeric oligonucleotides: high affinity or selectivity, a dilemma to design antisense oligomers. Nucleic Acids Res. 23:3434-3440.
45. Giles, R.V., Ruddell, C.J., Spiller, D.G., Green, J.A., and Tidd, D.M. 1995. Single base discrimination for ribonuclease H-dependent antisense effects within intact human leukaemia cells. Nucleic Acids Res. 23:954-961.
46. Keyomarsi, K. and Pardee, A.B. 1993. Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc. Natl. Acad. Sci. USA 90:1112-1116.
47. Hartwell, L.H. and Kastan, M.B. 1994. Cell cycle control and cancer. Science 266:1821-1828.
48. Froehler, B.C. 1993. Protocols for oligonucleotides and analogs: synthesis and properties. Humana, Totowa, NJ.
49. Froehler, B.C., Wadwani, S., Terhorst, T.J., and Gerrard, S.R. 1992. Oligodeoxynucleotides ontaining C-5 propyne analogs of 2′-deoxyuridine and 2′-deoxycytidine. Tetrahedron Lett. 33:5307-5310.
50. Froehler, B.C., Jones, R.J., Cao, X., and Terhorst, T.J. 1993. Oligonucleotides derived from 5-(1-propynyl)-2′-O-allyl-uridine and 5-(1-propynyl)-2′-O-allyl-cytidine: synthesis and RNA duplex formation. Tetrahedron Lett. 34:1003-1006.
51. Bram, R.J., Hung, D.T., Martin, P.K., Sohreiber, S.L., and Crabtree, G.R. 1993. Identification of the immunophilins capable of mediating inhibition of signal transduction by cyclosporin A and FK506: roles of calcineurin binding and cellular location. Mol. Cell. Biol. 13:4760-4769.
52. Jackman, M., Firth, M., and Pines, J. 1995. Human cyclins B1 and B2 are localized to strikingly different structures: B1 to microtubules, B2 primarily to the Golgi apparatus. EMBO J. 14:1646-1654.
53. Ausubel, F.M., Brent, R., Kingston, R.E., Morre, D.D., Seidman, J.G., Smith, J.A., and Struhl, K. (eds.). 1989. Current protocols in molecular biology. John Wiley and Sons, New York.
54. Quelle, D.E., Ashmun, R.A., Shurtleff, S.A., Kato, J.-Y., Bar-Sagi, D., Roussel, M.F., et al. 1993. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev. 7:1559-1571.